Key points are not available for this paper at this time.
You have accessJournal of UrologyKidney Cancer: Localized: Surgical Therapy II (PD33)1 May 2024PD33-12 CLINICAL RESULTS AFTER 1 YEAR OF IMPLEMENTING THE NOVEL SARA (SUPINE ANTERIOR RETROPERITONEAL ACCESS) APPROACH IN SINGLE-PORT ROBOTIC KIDNEY SURGERY Juan Ramon Torres Anguiano, Grace Luoyia Chen, Luca Alfredo Morgantini, Graham Hale, Rabun Jones, Ndubisi Onah, Antony Pellegrino, Ruben Sauer, Halsie Donaldson, Andrew Lai, and Simone Crivellaro Juan Ramon Torres AnguianoJuan Ramon Torres Anguiano , Grace Luoyia ChenGrace Luoyia Chen , Luca Alfredo MorgantiniLuca Alfredo Morgantini , Graham HaleGraham Hale , Rabun JonesRabun Jones , Ndubisi OnahNdubisi Onah , Antony PellegrinoAntony Pellegrino , Ruben SauerRuben Sauer , Halsie DonaldsonHalsie Donaldson , Andrew LaiAndrew Lai , and Simone CrivellaroSimone Crivellaro View All Author Informationhttps://doi.org/10.1097/01.JU.0001008912.25331.d7.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Robotic retroperitoneal access, while promising in prior studies, faced limited adoption due to its steep learning curve. The Single Port SARA technique simplifies access by introducing a supine patient position and a straightforward anatomical approach which also makes it more reproducible. We share the perioperative results after one year of implementing the novel supine anterior retroperitoneal approach (SARA) for kidney surgery. METHODS: We conducted a retrospective review of all patients who underwent SARA partial and radical nephrectomy procedures performed by a single urologic surgeon at our institution from October 2022 to October 2023. We analyzed the available preoperative clinical and demographic data, operative parameters, and postoperative outcomes. RESULTS: We included a cohort of 55 patients (Table 1). Our patient population primarily consisted of individuals at high perioperative risk (ASA≥3), with 78% falling into this category. Despite the elevated risk and a high comorbidity index, 78% of these patients were discharged on the same day as the procedure, and only 10% required opioid medication. Regarding surgical outcomes (Table 2), only 3% of patients experienced postoperative complications exceeding Clavien Dindo grade 3, necessitating readmission, and 98% of patients remained cancer-free up to the date of this submission. CONCLUSIONS: The SARA technique for renal surgery is both achievable and can be executed safely in various patient demographics, even in cases with multiple comorbidities, elevated BMI, and heightened anesthetic risks. In our study, renal surgeries could frequently be carried out on an outpatient basis, resulting in a low rate of hospital admissions. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e715 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Juan Ramon Torres Anguiano More articles by this author Grace Luoyia Chen More articles by this author Luca Alfredo Morgantini More articles by this author Graham Hale More articles by this author Rabun Jones More articles by this author Ndubisi Onah More articles by this author Antony Pellegrino More articles by this author Ruben Sauer More articles by this author Halsie Donaldson More articles by this author Andrew Lai More articles by this author Simone Crivellaro More articles by this author Expand All Advertisement PDF downloadLoading ...
Anguiano et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: